Fairvalue-Calculator Fairvalue-Calculator

Oscar Health, Inc (OSCR) Fair Value & Analysis

Healthcare · US · Market cap $7.1B

Price$29.16
Fair Value$58.32
Upside+100.0%
Quality95/100
Evidence: Low Range $37.56 – $90.78

Analysis

Oscar Health, Inc (OSCR) currently trades at $29.16, while our model-based Fair Value estimate is $58.32 — implying the stock looks roughly 100.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Open the full interactive analysis →

Similar stocks

UnitedHealth Group (UNH) -27% CVS Health Corporation (CVS) -25% Elevance Health, Inc (E1LV34) -19% The Cigna Group (CI) +69% Humana Inc (HUM) -65% Centene Corporation (CNC) +258%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.